Cargando…

Transition to Universal Same Day Discharge (SDD) in Times of Corona Virus Disease-19 (COVID): A Success Story

STUDY OBJECTIVE: To evaluate success of universal SDD after minimally invasive hysterectomy. The COVID pandemic presented a unique scenario in which universal SDD was implemented abruptly across study institutions. This allowed for evaluation of patients with characteristics under-represented in SDD...

Descripción completa

Detalles Bibliográficos
Autores principales: Cameo, T., Jenkins, J., Okuagu, C., Huang, R., Biest, S.W., Ross, W.T., Bardawil, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683825/
http://dx.doi.org/10.1016/j.jmig.2022.09.034
_version_ 1784835137575321600
author Cameo, T.
Jenkins, J.
Okuagu, C.
Huang, R.
Biest, S.W.
Ross, W.T.
Bardawil, E.
author_facet Cameo, T.
Jenkins, J.
Okuagu, C.
Huang, R.
Biest, S.W.
Ross, W.T.
Bardawil, E.
author_sort Cameo, T.
collection PubMed
description STUDY OBJECTIVE: To evaluate success of universal SDD after minimally invasive hysterectomy. The COVID pandemic presented a unique scenario in which universal SDD was implemented abruptly across study institutions. This allowed for evaluation of patients with characteristics under-represented in SDD literature: large uteri due to leiomyoma, obesity defined as body mass index (BMI) ≥30, and later surgical end time. DESIGN: Retrospective chart review with before/after study design comparing pre-COVID to COVID cohorts. SETTING: High-volume, academic and academic-affiliated medical centers. Due to COVID, in the after-cohort, surgery could only be scheduled if SDD was planned. PATIENTS OR PARTICIPANTS: Patients undergoing benign, laparoscopic or robotic-assisted hysterectomy during two 11-month periods: September 2018-July 2019 and May 2020-March 2021. INTERVENTIONS: Minimally invasive hysterectomy performed by three Minimally Invasive Gynecologic Surgeons. MEASUREMENTS AND MAIN RESULTS: 320 patients met inclusion criteria, 107 pre-COVID and 213 COVID. Mean age for both groups was 44.9. Patients were predominately non-Hispanic Black (40.2% pre- vs. 34.7% COVID) and non-Hispanic White (55.1% pre- vs. 63.4% COVID). Mean BMI was 33 for both groups. Pre-COVID, 2% of patients were discharged same day, whereas COVID 92% were discharged same day. Mean specimen weight was 478.2gm vs. 436.3gm for the two periods. In the COVID cohort, there was no difference in SDD success based on BMI (p 0.678), BMI <30 (49.5%), 30-39.9 (29.1%), 40-49.9 (15.3%), and ≥50 (6.1%). There was no difference in SDD success by specimen weight (p 0.077) stratified as <250gm (48.5%), 250-499gm (15.3%), or ≥500gm (36.2%). SDD success was not dependent on surgical end time (p 0.678) with end time stratified into ≤12:00 (45.4%), 12:01-14:59 (35.7%), and ≥15:00 (18.9%). There were no re-admissions in either cohort. CONCLUSION: Abrupt transition to SDD is safe and feasible, including for patients with obese BMI and enlarged uterus. SDD success was not affected by later surgical end time.
format Online
Article
Text
id pubmed-9683825
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-96838252022-11-25 Transition to Universal Same Day Discharge (SDD) in Times of Corona Virus Disease-19 (COVID): A Success Story Cameo, T. Jenkins, J. Okuagu, C. Huang, R. Biest, S.W. Ross, W.T. Bardawil, E. J Minim Invasive Gynecol Oral Session 3 - Laparoscopy (2:00 Pm—3:05 Pm) 2:10 Pm STUDY OBJECTIVE: To evaluate success of universal SDD after minimally invasive hysterectomy. The COVID pandemic presented a unique scenario in which universal SDD was implemented abruptly across study institutions. This allowed for evaluation of patients with characteristics under-represented in SDD literature: large uteri due to leiomyoma, obesity defined as body mass index (BMI) ≥30, and later surgical end time. DESIGN: Retrospective chart review with before/after study design comparing pre-COVID to COVID cohorts. SETTING: High-volume, academic and academic-affiliated medical centers. Due to COVID, in the after-cohort, surgery could only be scheduled if SDD was planned. PATIENTS OR PARTICIPANTS: Patients undergoing benign, laparoscopic or robotic-assisted hysterectomy during two 11-month periods: September 2018-July 2019 and May 2020-March 2021. INTERVENTIONS: Minimally invasive hysterectomy performed by three Minimally Invasive Gynecologic Surgeons. MEASUREMENTS AND MAIN RESULTS: 320 patients met inclusion criteria, 107 pre-COVID and 213 COVID. Mean age for both groups was 44.9. Patients were predominately non-Hispanic Black (40.2% pre- vs. 34.7% COVID) and non-Hispanic White (55.1% pre- vs. 63.4% COVID). Mean BMI was 33 for both groups. Pre-COVID, 2% of patients were discharged same day, whereas COVID 92% were discharged same day. Mean specimen weight was 478.2gm vs. 436.3gm for the two periods. In the COVID cohort, there was no difference in SDD success based on BMI (p 0.678), BMI <30 (49.5%), 30-39.9 (29.1%), 40-49.9 (15.3%), and ≥50 (6.1%). There was no difference in SDD success by specimen weight (p 0.077) stratified as <250gm (48.5%), 250-499gm (15.3%), or ≥500gm (36.2%). SDD success was not dependent on surgical end time (p 0.678) with end time stratified into ≤12:00 (45.4%), 12:01-14:59 (35.7%), and ≥15:00 (18.9%). There were no re-admissions in either cohort. CONCLUSION: Abrupt transition to SDD is safe and feasible, including for patients with obese BMI and enlarged uterus. SDD success was not affected by later surgical end time. Published by Elsevier Inc. 2022-11 2022-11-24 /pmc/articles/PMC9683825/ http://dx.doi.org/10.1016/j.jmig.2022.09.034 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Oral Session 3 - Laparoscopy (2:00 Pm—3:05 Pm) 2:10 Pm
Cameo, T.
Jenkins, J.
Okuagu, C.
Huang, R.
Biest, S.W.
Ross, W.T.
Bardawil, E.
Transition to Universal Same Day Discharge (SDD) in Times of Corona Virus Disease-19 (COVID): A Success Story
title Transition to Universal Same Day Discharge (SDD) in Times of Corona Virus Disease-19 (COVID): A Success Story
title_full Transition to Universal Same Day Discharge (SDD) in Times of Corona Virus Disease-19 (COVID): A Success Story
title_fullStr Transition to Universal Same Day Discharge (SDD) in Times of Corona Virus Disease-19 (COVID): A Success Story
title_full_unstemmed Transition to Universal Same Day Discharge (SDD) in Times of Corona Virus Disease-19 (COVID): A Success Story
title_short Transition to Universal Same Day Discharge (SDD) in Times of Corona Virus Disease-19 (COVID): A Success Story
title_sort transition to universal same day discharge (sdd) in times of corona virus disease-19 (covid): a success story
topic Oral Session 3 - Laparoscopy (2:00 Pm—3:05 Pm) 2:10 Pm
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683825/
http://dx.doi.org/10.1016/j.jmig.2022.09.034
work_keys_str_mv AT cameot transitiontouniversalsamedaydischargesddintimesofcoronavirusdisease19covidasuccessstory
AT jenkinsj transitiontouniversalsamedaydischargesddintimesofcoronavirusdisease19covidasuccessstory
AT okuaguc transitiontouniversalsamedaydischargesddintimesofcoronavirusdisease19covidasuccessstory
AT huangr transitiontouniversalsamedaydischargesddintimesofcoronavirusdisease19covidasuccessstory
AT biestsw transitiontouniversalsamedaydischargesddintimesofcoronavirusdisease19covidasuccessstory
AT rosswt transitiontouniversalsamedaydischargesddintimesofcoronavirusdisease19covidasuccessstory
AT bardawile transitiontouniversalsamedaydischargesddintimesofcoronavirusdisease19covidasuccessstory